Literature DB >> 32082806

Completion pneumonectomy: Indications and outcomes in non-small cell lung cancer.

Serkan Yazgan1, Ahmet Üçvet1, Soner Gürsoy1, Özgür Samancılar1.   

Abstract

BACKGROUND: This retrospective single-center study aims to review the indications and outcomes of completion pneumonectomy after primary resection due to non-small cell lung cancer.
METHODS: Of a total of 452 patients who underwent pneumonectomy between January 2004 and August 2017 for non-small cell lung cancer, 29 (24 males, 5 females; mean age 59.9±7.1 years; range, 45 to 72 years) were performed completion pneumonectomy. Patients" indications, factors affecting early and late-term outcomes, operative mortality and survival rates were analyzed.
RESULTS: Operative mortality rate was 24.1%, including two intraoperative and five postoperative deaths. Complication rate was 44.8% and the most frequent complication was bronchopleural fistula with 24.1%. Study population was divided into two groups. While elective completion pneumonectomy group (n=19) consisted of recurrent malignant tumor patients, rescue completion pneumonectomy group (n=10) consisted of patients performed urgent pneumonectomy due to a bronchopulmonary complication developing after an anatomic lung resection. The morbidity and mortality rates for elective completion pneumonectomy and rescue completion pneumonectomy were 26.3% and 21.1%; and 70% and 30%, respectively. The morbidity for rescue completion pneumonectomy was significantly higher than elective completion pneumonectomy (p=0.016). Advanced age and presence of any preoperative risk (comorbidity and neoadjuvant treatment) were related to higher operative mortality (p=0.019 and p=0.049, respectively). The median survival after completion pneumonectomy was 19.5 months (95% confidence interval 17.2 to 21.9 months).
CONCLUSION: The morbidity and mortality rates of completion pneumonectomy are higher than standard pneumonectomy. Rescue completion pneumonectomy is related to higher postoperative risk, but has better survival. The most significant complication after completion pneumonectomy is bronchopleural fistula. Advanced age and presence of any preoperative risk are related to statistically significantly higher mortality in completion pneumonectomy. Nevertheless, completion pneumonectomy is still a significant treatment option in selected patients.
Copyright © 2018, Turkish Society of Cardiovascular Surgery.

Entities:  

Keywords:  Completion pneumonectomy; early mortality; indication; non-small cell lung cancer; survival rate

Year:  2018        PMID: 32082806      PMCID: PMC7018186          DOI: 10.5606/tgkdc.dergisi.2018.16159

Source DB:  PubMed          Journal:  Turk Gogus Kalp Damar Cerrahisi Derg        ISSN: 1301-5680            Impact factor:   0.332


  31 in total

1.  Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy.

Authors:  J Martin; R J Ginsberg; A Abolhoda; M S Bains; R J Downey; R J Korst; T L Weigel; M G Kris; E S Venkatraman; V W Rusch
Journal:  Ann Thorac Surg       Date:  2001-10       Impact factor: 4.330

2.  Second surgical intervention for recurrent and second primary bronchogenic carcinomas.

Authors:  Y Watanabe; J Shimizu; M Oda; Y Tatsuzawa; Y Hayashi; T Iwa
Journal:  Scand J Thorac Cardiovasc Surg       Date:  1992

3.  The early and long-term outcomes of completion pneumonectomy: report of 56 cases.

Authors:  Xufeng Pan; Shijie Fu; Jianxin Shi; Jun Yang; Heng Zhao
Journal:  Interact Cardiovasc Thorac Surg       Date:  2014-06-03

4.  Completion pneumonectomy: indications, complications, and results.

Authors:  E M McGovern; V F Trastek; P C Pairolero; W S Payne
Journal:  Ann Thorac Surg       Date:  1988-08       Impact factor: 4.330

5.  Completion pneumonectomy: a multicentre international study on 165 patients.

Authors:  Giuseppe Cardillo; Domenico Galetta; Paul van Schil; Andrea Zuin; Pierluigi Filosso; Robert J Cerfolio; Anna Rita Forcione; Francesco Carleo
Journal:  Eur J Cardiothorac Surg       Date:  2012-03-06       Impact factor: 4.191

6.  Stereotactic Body Radiation Therapy (SBRT) for Recurrent Non-small Cell Lung Cancer (NSCLC).

Authors:  Stefan Janssen; Lukas Käsmann; Volker Rudat; Dirk Rades
Journal:  Anticancer Res       Date:  2016-02       Impact factor: 2.480

7.  Completion pneumonectomy: factors affecting operative mortality and cardiopulmonary morbidity.

Authors:  Daniel L Miller; Claude Deschamps; Gregory D Jenkins; Alain Bernard; Mark S Allen; Peter C Pairolero
Journal:  Ann Thorac Surg       Date:  2002-09       Impact factor: 4.330

8.  Resection for second and third primary lung cancer.

Authors:  L P Faber
Journal:  Semin Surg Oncol       Date:  1993 Mar-Apr

9.  Factors affecting early and long-term outcomes after completion pneumonectomy.

Authors:  Olivier Chataigner; Elie Fadel; Bedrettin Yildizeli; Abdallah Achir; Sacha Mussot; Dominique Fabre; Olaf Mercier; Philippe G Dartevelle
Journal:  Eur J Cardiothorac Surg       Date:  2008-03-14       Impact factor: 4.191

10.  [Completion pneumonectomy--a review of 29 cases].

Authors:  H Oizumi; T Naruke; H Watanabe; T Sano; H Kondo; T Goya; R Tsuchiya; K Suemasu
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1990-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.